ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Board Meeting to discuss
Financial Results To consider and approve the financial results for the period ended June 30, 2025
Announcement as on 05 August 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
Announcement as on 04 August 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Announcement as on 25 July 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange about Presentation
Announcement as on 17 July 2025

Glenmark Pharmaceuticals targets 70% branded portfolio by 2030, boosts focus on novel drugs
Glenmark Pharmaceuticals is transitioning into an innovation-driven company over the next 4-5 years, emphasizing its novel drug portfolio and strengthening its branded business. By 2030, the company aims for 70% of its revenue to come from branded products
Announcement as on 17 July 2025

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2074.24
  • 12Day Average: 2045.82
  • 20Day Average: 2018.44
  • 50Day Average: 1941.44
  • 100Day Average: 1955.43
  • 150Day Average: 1940.46
  • 200Day Average: 1813.78

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2047.71, 2009.71, 33.09
Indicator MACD is in positive zone

Indicator ADX (14)

50.41, 32.78, 10.81
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Thu Jan 2026 2079.80 2074.00 to 2122.10 -1.58% 0.66 times
07 Wed Jan 2026 2113.10 2070.70 to 2147.50 1.86% 2.06 times
06 Tue Jan 2026 2074.60 2031.50 to 2080.80 1.74% 0.36 times
05 Mon Jan 2026 2039.20 2031.50 to 2091.80 -1.23% 0.54 times
02 Fri Jan 2026 2064.50 2021.00 to 2073.00 1.89% 0.62 times
01 Thu Jan 2026 2026.20 2011.00 to 2039.10 -0.44% 0.45 times
31 Wed Dec 2025 2035.20 2025.70 to 2048.40 0.27% 0.58 times
30 Tue Dec 2025 2029.80 2000.00 to 2039.00 1% 3.71 times
29 Mon Dec 2025 2009.70 2000.40 to 2028.50 -0.04% 0.43 times
26 Fri Dec 2025 2010.60 2004.30 to 2025.90 -0.47% 0.33 times
24 Wed Dec 2025 2020.10 2013.80 to 2054.90 -1.31% 0.93 times
23 Tue Dec 2025 2047.00 2036.50 to 2082.50 0.43% 2.26 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top